During the past decade, North Mississippi Medical Center conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 23 clinical trials were completed, i.e. on average, 67.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 13 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Mississippi Medical Center" #1 sponsor was "Boston Scientific Corporation" with 16 trials, followed by "Abbott Medical Devices" with 14 trials sponsored, "Osprey Medical, Inc" with 3 trials sponsored, "Shockwave Medical, Inc." with 3 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Mississippi Medical Center" #1 collaborator was "Abiomed Inc." with 1 trials as a collaborator, "Chiesi Farmaceutici S.p.A." with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "North Mississippi Medical Center" are "Coronary Artery Disease" (16 trials), "Heart Failure" (7 trials), "Atrial Fibrillation" (3 trials), "Stroke" (3 trials) and "Coronary Artery Stenosis" (2 trials). Many other conditions were trialed in "North Mississippi Medical Center" in a lesser frequency.

Most popular intervention types in "North Mississippi Medical Center" are "Device" (48 trials), "Drug" (10 trials), "Other" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "TAXUS Liberté-SR" (3 trials), "Aspirin" (2 trials), "PROMUS Element Coronary Stent System" (2 trials), "Placebo" (2 trials) and "Radiofrequency Ablation" (2 trials). Other intervention names were less common.

The vast majority of trials in "North Mississippi Medical Center" are 58 trials for "All" genders.

Currently, there are NaN active trials in "North Mississippi Medical Center". undefined are not yet recruiting, 9 are recruiting, 11 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 29 completed trials in North Mississippi Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in North Mississippi Medical Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 30 trials that are defined as “Not Applicable".

North Mississippi Medical Center has several departments that took part in Clinical trials: "North Mississippi Medical Center/Cancer Center" - 33 trials, "North Mississippi Medical Ctr; Internal Medicine Associates" - 2 trials, "North Mississippi Sports Medicine & Orthopaedic Clinic" - 2 trials